Nolato AB (publ) (NOLA_B) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nolato Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.071 -- 00:00:04.933 Hello and welcome to today's broadcast with Olato, who will be presenting their financial 00:00:04.933 -- 00:00:08.014 report for the second quarter of 2026. 00:00:08.014 -- 00:00:13.837 With us, we have the CEO, Christer Wallqvist, and CFO, Per-Ola Holmström. 00:00:13.837 -- 00:00:18.279 If you wish to ask questions, you can do so via the form found to the right of the broadcast, 00:00:18.279 -- 00:00:23.121 and if you're calling and would like to ask a question, press star 9 to raise your hand 00:00:23.121 -- 00:00:26.494 and star 6 to activate your audio once you've been given the word. 00:00:26.494 -- 00:00:29.195 With that said, I hand it over to you, Christian Perola. 00:00:29.195 -- 00:00:31.476 The floor is yours. 00:00:31.476 -- 00:00:37.578 Thank you and welcome to the presentation of the second quarter for Nolato Group. 00:00:37.819 -- 00:00:42.821 Starting on page two, we saw a quarter with growth in both business 00:00:42.821 -- 00:00:47.943 areas with a total growth of 4% currency adjusted 00:00:47.943 -- 00:00:52.248 with the strongest growth in the medical business area. 00:00:52.248 -- 00:00:59.034 This was achieved in a difficult environment, I would say. 00:00:59.316 -- 00:01:04.762 So sales ended up at close to 2.5 billions 00:01:04.762 -- 00:01:10.274 in the quarter, and that was then 4% adjusted currency growth. 00:01:10.274 -- 00:01:15.900 The profit EBITDA ended up at 247 millions, 00:01:15.900 -- 00:01:19.024 creating a margin of 10.1%. 00:01:19.024 -- 00:01:24.791 The margin was affected by increased raw material prices 00:01:24.791 -- 00:01:28.673 and some startup costs for new programs. 00:01:29.223 -- 00:01:34.407 strong cash flow in the in the quarter ended up at 287 millions 00:01:34.407 -- 00:01:39.6...